Skip to content
Menu
About Us
Overview
Management Team
Board of Directors
Contact Us
Royalty Portfolio
Opportunities
Overview
Royalty Acquisition
Assets Available for Licensing
Phage Display Platform
Ebopiprant
Anti-prolactin Antibody
XMetA Portfolio
News
Company & Partner News
Press Releases
Investors
Overview
News & Events
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Governance
Contact
Menu
About Us
Overview
Management Team
Board of Directors
Contact Us
Royalty Portfolio
Opportunities
Overview
Royalty Acquisition
Assets Available for Licensing
Phage Display Platform
Ebopiprant
Anti-prolactin Antibody
XMetA Portfolio
News
Company & Partner News
Press Releases
Investors
Overview
News & Events
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Governance
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Company & Partner News
Press Releases
IR Calendar
Email Alerts
Financial Information
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Overview
Charts
Historical Data
IRS Form 8937
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
All SEC Filings
Filing Type:
View All
10-C
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
8-K12G3
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PRER14A
RW
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
1998
1996
Date
Form
Description
PDF
XBRL
Pages
05/08/12
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-99.1
61
04/23/12
3
Initial statement of beneficial ownership of securities
2
04/23/12
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-99.1
9
04/11/12
DEF 14A
Definitive proxy statements
57
04/11/12
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
5
04/02/12
4
Statement of changes in beneficial ownership of securities
2
03/29/12
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
57
03/16/12
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
03/14/12
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-4.9
EX-10.6A
EX-10.6B
EX-10.7B
EX-10.10G
EX-10.12A
EX-10.25B
EX-10.41A
EX-10.43
EX-10.43A
EX-10.44
EX-10.44A
EX-10.45
EX-10.45A
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-99.1
477
03/12/12
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
10
Previous
78
79
80
81
82
83
84
85
86
87
Next
Email Alerts
RSS News Feed
Scroll back to top